OBJECTIVE: Body size is an important modifiable risk factor for breast cancer. Although
obesity has generally been found to be associated with increased risk for postmenopausal …

Background High levels of androgens and estrogens have been reported to be associated
with breast cancer. However, the multiplicity of factors that influence hormone levels and …

Objectives To compare the efficacy and safety of low molecular weight heparin (LMWH) and
oral anticoagulants for the long‐term treatment of venous thromboembolism (VTE) in …

Exposure to estrogens is associated with increased risk of breast and other types of human
cancer. Estrogens are converted to metabolites, particularly the catechol estrogen-3,4-…

Oxidative stress has been implicated in the etiology of many chronic diseases, including
cardiovascular disease. However, limited information exists on the factors that may influence …

There is some evidence that glucose and other factors related to glucose metabolism, such
as insulin and insulin-like growth-factors (IGFs) may contribute to breast cancer development…

Experimental and clinical evidence suggests that 16α-hydroxylated estrogen metabolites,
biologically strong estrogens, are associated with breast cancer risk, while 2-hydroxylated …

Background The prevalence of obesity is increasing, and there is evidence that obesity, in
particular abdominal obesity as a marker of insulin resistance, is negatively associated with …

Experimental and epidemiological data support a role for sex steroid hormones in the
pathogenesis of endometrial cancer. The associations of pre‐diagnostic blood concentrations of …

Regional body fat distribution may represent an independent risk factor for several conditions,
especially metabolic and cardiovascular diseases; recent findings have shown that …